151 related articles for article (PubMed ID: 28145839)
21. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
[TBL] [Abstract][Full Text] [Related]
22. Cervical Lymph Node Metastases After Thyroidectomy for Papillary Thyroid Carcinoma Usually Remain Stable for Years.
Tomoda C; Sugino K; Matsuzu K; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Ito K
Thyroid; 2016 Dec; 26(12):1706-1711. PubMed ID: 27616725
[TBL] [Abstract][Full Text] [Related]
23. Cervical lymph node metastases: diagnosis at sonoelastography--initial experience.
Lyshchik A; Higashi T; Asato R; Tanaka S; Ito J; Hiraoka M; Insana MF; Brill AB; Saga T; Togashi K
Radiology; 2007 Apr; 243(1):258-67. PubMed ID: 17293571
[TBL] [Abstract][Full Text] [Related]
24. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
[TBL] [Abstract][Full Text] [Related]
25. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
26. Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence.
Roh JL; Kim JM; Park CI
Ann Surg Oncol; 2011 Aug; 18(8):2245-50. PubMed ID: 21327454
[TBL] [Abstract][Full Text] [Related]
27. Prophylactic lymphadenectomy of neck level II in clinically node-positive papillary thyroid carcinoma.
Koo BS; Seo ST; Lee GH; Kim JM; Choi EC; Lim YC
Ann Surg Oncol; 2010 Jun; 17(6):1637-41. PubMed ID: 20146100
[TBL] [Abstract][Full Text] [Related]
28. [A case of malignant lymphoma that seemed to be thyroid cancer lymph nodes recurrence].
Enomoto K; Sakurai K; Amano S; Shiono M
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2213-5. PubMed ID: 19106574
[TBL] [Abstract][Full Text] [Related]
29. Axillary lymph nodes suspicious for breast cancer metastasis: sampling with US-guided 14-gauge core-needle biopsy--clinical experience in 100 patients.
Abe H; Schmidt RA; Kulkarni K; Sennett CA; Mueller JS; Newstead GM
Radiology; 2009 Jan; 250(1):41-9. PubMed ID: 18955508
[TBL] [Abstract][Full Text] [Related]
30. Enlarged benign-appearing cervical lymph nodes by ultrasonography are associated with increased likelihood of cancer somewhere within the thyroid in patients undergoing thyroid nodule evaluation.
Hands KE; Cervera A; Fowler LJ
Thyroid; 2010 Aug; 20(8):857-62. PubMed ID: 20615130
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck.
Lee CW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Jan; 22(1):117-24. PubMed ID: 25034816
[TBL] [Abstract][Full Text] [Related]
32. Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study.
Joo JY; Park JY; Yoon YH; Choi B; Kim JM; Jo YS; Shong M; Koo BS
J Clin Endocrinol Metab; 2012 Nov; 97(11):3996-4003. PubMed ID: 22930785
[TBL] [Abstract][Full Text] [Related]
33. Analysis of the prognostic significance of lymph node related characteristics in papillary thyroid carcinoma patients presenting with pre- or intra-operative evidence of cervical lymph node metastases.
Soudry E; Hilly O; Preis M; Hadar T; Segal K; Bachar G; Feinmesser R
J Laryngol Otol; 2014 Mar; 128(3):284-8. PubMed ID: 24636046
[TBL] [Abstract][Full Text] [Related]
34. Incidence of metastatic well-differentiated thyroid cancer in cervical lymph nodes.
Wang TS; Dubner S; Sznyter LA; Heller KS
Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):110-3. PubMed ID: 14732779
[TBL] [Abstract][Full Text] [Related]
35. Predictive value of metastatic cervical lymph node ratio in papillary thyroid carcinoma recurrence.
Yip J; Orlov S; Orlov D; Vaisman A; Hernández KG; Etarsky D; Kak I; Parvinnejad N; Freeman JL; Walfish PG
Head Neck; 2013 Apr; 35(4):592-8. PubMed ID: 22730192
[TBL] [Abstract][Full Text] [Related]
36. Selective lateral compartment neck dissection for thyroid cancer.
Welch K; McHenry CR
J Surg Res; 2013 Sep; 184(1):193-9. PubMed ID: 23816244
[TBL] [Abstract][Full Text] [Related]
37. Level VI node size as a predictor of malignancy in papillary thyroid cancer.
Macdonald KI; Taylor SM; Cavanagh J; Trites JR; Bullock MJ; Hart RD
J Otolaryngol Head Neck Surg; 2010 Apr; 39(2):136-41. PubMed ID: 20211099
[TBL] [Abstract][Full Text] [Related]
38. [Distribution of cervical lymph node metastasis in well-differentiated thyroid carcinoma].
Bian X; Xu ZG; Zhang B; Liu WS; Mao CY; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Aug; 41(8):599-602. PubMed ID: 17039802
[TBL] [Abstract][Full Text] [Related]
39. 18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.
Troost EG; Vogel WV; Merkx MA; Slootweg PJ; Marres HA; Peeters WJ; Bussink J; van der Kogel AJ; Oyen WJ; Kaanders JH
J Nucl Med; 2007 May; 48(5):726-35. PubMed ID: 17475960
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of the ultrasonographic features of axillary lymph node metastasis in breast cancer].
Wang YB; Zhang H; Gao W; Zhang L; Yan K; Yin SS; Chen MH
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):65-9. PubMed ID: 16737626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
